Sunday, March 16, 2025 | 04:43 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Emergency approval for vaccine should come by Dec-Jan: AIIMS director

Randeep Guleria say data showed that in the short term the vaccine is safe

Randeep Guleria, AIIMS director
Premium

Randeep Guleria, AIIMS director. Credits: AIIMS Gallery

Ruchika Chitravanshi New Delhi
India may get emergency-use authorisation for a coronavirus vaccine from regulators by the end of December or early January, with several candidates now in the final stage of trials, Dr Randeep Guleria, director, All India Institute of Medical Science said on Thursday. 

Speaking to ANI, Guleria said that the data showed that in the short term the vaccine is safe. “There is good data available that the vaccines are very safe. Safety and efficacy of vaccines not compromised at all. Around 70,000-80,000 volunteers have been given vaccines in trials with no significant serious adverse effects seen.”

Russia was the first

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in